Hanoi - A New Dawn in Public Health

In a significant advancement in public health, Takeda, a renowned global biopharmaceutical company, recently unveiled a groundbreaking dengue vaccine during a series of scientific symposia held on September 26 and 27 in Ho Chi Minh City and Hanoi. This event was organized in conjunction with the Pasteur Institute in Ho Chi Minh City and the Vietnam Association of Prevention Medicine (VAPM), bringing together nearly 1,000 experts, healthcare professionals, and government officials to discuss innovative strategies for dengue management.

Symposium Details and Objectives

The symposia, titled "Vaccine: A New Paradigm in Dengue Fever Prevention in Vietnam," aimed not only to provide vital information about the newly available vaccine but also to encourage collaboration among healthcare entities, thereby strengthening dengue prevention initiatives throughout the nation.

Vaccine Approval and Public Health Impact

Approved by the Drug Administration of Vietnam in May 2024, the dengue vaccine is expected to be a crucial part of an integrated approach to combatting this widespread disease. Dengue fever, recognized as a significant public health threat by the World Health Organization (WHO), affects over 390 million people globally each year and is endemic in more than 100 countries. In Vietnam, the dengue situation has become alarming, with increased incidence rates throughout recent years and unpredictable patterns that challenge traditional preventive measures.

Emerging Trends and Urgency for Action

The recent trend shows that certain regions, previously less affected, are now experiencing dengue outbreaks. Historically, Vietnam saw peak dengue cases approximately every ten years. However, the last decade revealed a troubling double peak in 2019 and again in 2022, leading experts to call for urgent action from the healthcare community.

Expert Opinions on Dengue Prevention

Leading voices at the symposium, including Assoc. Prof. Nguyen Vu Trung and Prof. Phan Trong Lan, highlighted the urgency for enhanced preventive measures amid the evolving landscape of the disease. "Our government, healthcare agencies, and citizens are increasingly aware of the pressing need for action in dengue prevention," stated Prof. Lan. The introduction of the dengue vaccine, combined with efforts in vector control and personal protection, represents a timely solution to mitigate the burden on Vietnam's healthcare systems.

Transformational Potential of the Vaccine

Prominent speakers included Dr. Derek Wallace, President of Global Vaccine Business at Takeda, who emphasized the vaccine's potential to transform dengue prevention strategies. "This vaccine is not just another tool; it represents a significant breakthrough in tackling dengue fever and achieving better public health outcomes," he said.

Global Reception of the Vaccine

The event not only focused on the new vaccine's capabilities but also showcased extensive research into its safety and effectiveness, drawing insights from global counterparts like Thailand, which has long battled high dengue burdens. Experts underscored that as the disease's challenges grow more complex, the need for innovative medical responses becomes ever more critical.

Celebration of Dedication

Moreover, Takeda's dengue vaccine has been well-received worldwide, with approvals spanning over 40 countries. It is incorporated into public vaccination programs in several nations such as Brazil and Indonesia, which underscores its potential to curb the spread of dengue in areas most afflicted.

A Tribute to Efforts

In a poignant tribute to the ongoing efforts in dengue prevention, a photo exhibition titled “Three-Decade Journey of Preventing and Controlling Dengue Fever in Vietnam” also took place, celebrating the dedication of Vietnam’s healthcare professionals.

Hope for the Future

With climate change and urbanization contributing to the rising incidence of dengue, the introduction of vaccination provides a new hope in a long-standing public health challenge. As Vietnam steps into this new era in dengue prevention, the fusion of innovative healthcare measures with robust community engagement stands to improve outcomes for countless lives, paving the way for a healthier future.